Eisner Mark (CIK 0001834161)

Latest company ownership

FGEN - FIBROGEN INC
Role: EVP, Chief Medical Officer
Shares held
159,917
Last filed at
Sep 8, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
VIR - Vir Biotechnology, Inc.
Role: EVP and Chief Medical Officer
Shares held
104,618
Last filed at
Jul 17, 2025
Confidence Score
46.3
2025Q4
Confidence Score History
2025Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 15, 2025 Jul 17, 2025 Vir Biotechnology, Inc. EVP and Chief Medical Officer Sell 28.8 -10,382 -9.03% ✓ $56.8K
Sep 6, 2023 Sep 8, 2023 FIBROGEN INC EVP, Chief Medical Officer Sell 27.5 -1,860 -1.15% ✗ $1.8K
Sep 1, 2023 Sep 6, 2023 FIBROGEN INC EVP, Chief Medical Officer Sell 37.5 -1,085 -0.67% ✗ $1.2K
Jun 7, 2023 Jun 9, 2023 FIBROGEN INC EVP, Chief Medical Officer Sell 26.3 -2,042 -1.24% ✗ $34.8K
Jun 2, 2023 Jun 5, 2023 FIBROGEN INC EVP, Chief Medical Officer Sell 36.3 -1,090 -0.66% ✗ $20.5K
Apr 4, 2023 Apr 6, 2023 FIBROGEN INC Chief Medical Officer Sell 22.5 -9,182 -5.24% ✗ $172.5K
Mar 8, 2023 Mar 10, 2023 FIBROGEN INC Chief Medical Officer Sell 85.0 +2,680 1.55% ✗ $360.6K
Mar 2, 2023 Mar 6, 2023 FIBROGEN INC Chief Medical Officer Sell 36.3 -1,187 -0.68% ✗ $26K
Dec 1, 2022 Dec 2, 2022 FIBROGEN INC Chief Medical Officer Sell 36.3 -1,084 -0.76% ✗ $16.3K
Sep 30, 2022 Oct 4, 2022 FIBROGEN INC Chief Medical Officer Sell 22.5 -6,777 -4.55% ✗ $88.2K
Sep 1, 2022 Sep 2, 2022 FIBROGEN INC Chief Medical Officer Sell 37.5 -756 -0.50% ✗ $9.9K
Jun 1, 2022 Jun 3, 2022 FIBROGEN INC Chief Medical Officer Sell 36.3 -1,141 -0.76% ✗ $11K
Mar 31, 2022 Apr 1, 2022 FIBROGEN INC Chief Medical Officer Sell 22.5 -6,442 -4.09% ✗ $77.4K
Mar 1, 2022 Mar 3, 2022 FIBROGEN INC Chief Medical Officer Sell 43.8 -756 -0.48% ✗ $10.3K
Jan 3, 2022 Jan 5, 2022 FIBROGEN INC Chief Medical Officer Sell 22.5 -7,043 -6.70% ✗ $104.4K
Dec 1, 2021 Dec 3, 2021 FIBROGEN INC Chief Medical Officer Sell 22.5 -4,338 -3.96% ✗ $54.9K